Literature DB >> 17696161

Congenital defects among liveborn infants with Down syndrome.

Mario A Cleves1, Charlotte A Hobbs, Phillip A Cleves, John M Tilford, T M Bird, James M Robbins.   

Abstract

BACKGROUND: Many infants with Down syndrome (DS) have co-occurring congenital malformations requiring intensive surgical and medical management. To anticipate the care needed by these infants, providers and parents require accurate information about birth defects that may be present. This article uses a unique national hospital discharge dataset to identify the rate at which structural birth defects are identified among liveborn infants with DS.
METHODS: ICD-9-CM diagnosis codes for data from the Healthcare Cost and Utilization Project were used to identify infants with and without DS, and to classify birth defects. The study population consisted of liveborn infants discharged from the hospital from 1993 through 2002. ORs for the association between the occurrence of congenital malformations and the presence of DS were computed using logistic regression models for survey data.
RESULTS: Discharge data included 11,372 DS and 7,884,209 non-DS births, representing national estimates of 43,463 DS and 39,716,469 non-DS births respectively. In addition to congenital heart defects that co-occurred most often in DS infants compared to infants without DS, the risks for gastrointestinal malformations (OR 67.07), genitourinary malformations (OR 3.62), orofacial malformations (OR 5.63), and abdominal wall malformations (OR 3.25) were also elevated in infants with DS. There was no difference in the risk of spina bifida between infants with and without DS.
CONCLUSIONS: This is the first nationally representative compilation of the co-occurrence of congenital malformations associated with DS. This information may assist providers and parents in their attempts to understand and prepare for the true burden of this condition.

Entities:  

Mesh:

Year:  2007        PMID: 17696161     DOI: 10.1002/bdra.20393

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  26 in total

1.  Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.

Authors:  Joshua D Blazek; Anna Gaddy; Rachel Meyer; Randall J Roper; Jiliang Li
Journal:  Bone       Date:  2010-09-24       Impact factor: 4.398

2.  Clinical identification of feeding and swallowing disorders in 0-6 month old infants with Down syndrome.

Authors:  Maria A Stanley; Nicole Shepherd; Nichole Duvall; Sandra B Jenkinson; Hasnaa E Jalou; Deborah C Givan; Gregory H Steele; Charlene Davis; Marilyn J Bull; Donna U Watkins; Randall J Roper
Journal:  Am J Med Genet A       Date:  2018-12-27       Impact factor: 2.802

3.  Co-occurring defect analysis: A platform for analyzing birth defect co-occurrence in registries.

Authors:  Renata H Benjamin; Xiao Yu; Maria Luisa Navarro Sanchez; Han Chen; Laura E Mitchell; Peter H Langlois; Mark A Canfield; Michael D Swartz; Angela E Scheuerle; Daryl A Scott; Hope Northrup; Christian P Schaaf; Joseph W Ray; Scott D McLean; Philip J Lupo; A J Agopian
Journal:  Birth Defects Res       Date:  2019-07-16       Impact factor: 2.344

4.  Consideration of VACTERL association in patients with trisomy 21.

Authors:  Benjamin D Solomon; Sophia M Bous; Simona Bianconi; Daniel E Pineda-Alvarez
Journal:  Clin Dysmorphol       Date:  2010-10       Impact factor: 0.816

5.  Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.

Authors:  Mehrdad Faizi; Patrick L Bader; Christine Tun; Angelo Encarnacion; Alexander Kleschevnikov; Pavel Belichenko; Nay Saw; Matthew Priestley; Richard W Tsien; William C Mobley; Mehrdad Shamloo
Journal:  Neurobiol Dis       Date:  2011-04-17       Impact factor: 5.996

6.  Racial/ethnic differences in hospital use and cost among a statewide population of children with Down syndrome.

Authors:  Taletha Mae Derrington; Milton Kotelchuck; Katrina Plummer; Howard Cabral; Angela E Lin; Candice Belanoff; Mikyong Shin; Adolfo Correa; Scott D Grosse
Journal:  Res Dev Disabil       Date:  2013-07-26

7.  Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome.

Authors:  A Contestabile; T Fila; A Cappellini; R Bartesaghi; E Ciani
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

Review 8.  Possible association of Down syndrome and exstrophy-epispadias complex: report of two new cases and review of the literature.

Authors:  Heiko Reutter; Arend Bökenkamp; Anne-Karolin Ebert; Wolfgang Rösch; Thomas M Boemers; Markus M Nöthen; Michael Ludwig
Journal:  Eur J Pediatr       Date:  2008-10-16       Impact factor: 3.183

Review 9.  Down syndrome and the enteric nervous system.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2008-07-17       Impact factor: 1.827

10.  Hirschsprung's disease associated with Down syndrome: a meta-analysis of incidence, functional outcomes and mortality.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.